← Oncology Approval Tracker

FDA DECISION ·

Bosutinib (Bosulif reference)

bosutinib monohydrate · Alembic Pharmaceuticals

First generic approvalFirst genericChronic myeloid leukemia
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic 100 mg and 500 mg tablets for adults with newly diagnosed chronic-phase Philadelphia chromosome-positive CML, or chronic-, accelerated-, or blast-phase disease resistant or intolerant to prior therapy.

LAMPGEN ANALYSIS

Why it matters

A generic tablet adds a potential source for BCR::ABL1 inhibition in chronic-phase CML.

What research teams should watch

Verify the available tablet strength and maintain molecular response, renal function, and adverse-event follow-up across products.

PRIMARY RECORDS

Sources